1. Home
  2. SKWD vs NUVB Comparison

SKWD vs NUVB Comparison

Compare SKWD & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skyward Specialty Insurance Group Inc.

SKWD

Skyward Specialty Insurance Group Inc.

N/A

Current Price

$58.76

Market Cap

2.4B

Sector

Finance

ML Signal

N/A

Logo Nuvation Bio Inc.

NUVB

Nuvation Bio Inc.

N/A

Current Price

$4.97

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SKWD
NUVB
Founded
2007
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.1B
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
SKWD
NUVB
Price
$58.76
$4.97
Analyst Decision
Buy
Strong Buy
Analyst Count
13
13
Target Price
★ $70.45
$13.00
AVG Volume (30 Days)
310.2K
★ 5.1M
Earning Date
11-05-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
41.81
★ 71.56
EPS
★ 2.17
N/A
Revenue
★ $1,416,541,000.00
$62,902,000.00
Revenue This Year
$39.34
$211.79
Revenue Next Year
$6.68
$45.15
P/E Ratio
$27.33
★ N/A
Revenue Growth
23.16
★ 698.96
52 Week Low
$40.60
$3.36
52 Week High
$65.69
$9.75

Technical Indicators

Market Signals
Indicator
SKWD
NUVB
Relative Strength Index (RSI) 60.91 29.49
Support Level $55.18 $4.10
Resistance Level $58.81 $5.16
Average True Range (ATR) 1.47 0.24
MACD 0.59 -0.06
Stochastic Oscillator 83.12 20.80

Price Performance

Historical Comparison
SKWD
NUVB

About SKWD Skyward Specialty Insurance Group Inc.

Skyward Specialty Insurance Group Inc is a specialty insurance company that offers a suite of specialized insurance solutions across specialty property and casualty markets on a non-admitted and admitted basis. Its portfolio of insurance offerings covers a wide variety of risks, including general liability, commercial auto, group accident and health, property, agriculture, credit, surety, and workers' compensation, among others. Geographically, the group mainly operates in the United States.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: